Monday, August 31, 2026

Strengthening U.S.-Korea Public Diplomacy: Key Insights from Assistant Secretary Rogers’ Visit

U.S. Deputy Secretary Sarah Rogers visits South Korea to enhance public diplomacy and discuss digital freedom and collaboration in the Indo-Pacific.

U.S. Pressures South Korea to Join High-Stakes Military Operation Project Freedom

U.S. urges South Korea to join Project Freedom after Iranian attack on HMM Namu, emphasizing the need for collective maritime security.

How AI is Changing the Game for Drug Makers!

This joint initiative aims to reduce the costs and time associated with new drug development using AI models based on federated learning.

Tag: Rivoceranib

HLB’s Rivoceranib Drug Approval: What the FDA’s VAI Classification Means for Liver Cancer Treatment

HLB's Rivoceranib facility received a VAI classification from the FDA, indicating compliance with GMP standards, aiding drug approval progress.

HLB’s Liver Cancer Drug: FDA’s VAI Conclusion Sparks Hope for Approval

HLB's Rivoceranib facility passed FDA inspection, receiving VAI classification, moving towards new liver cancer drug approval.

Top News

- Our Sponsors Ad -

Follow us